NKARTA INC. - COMMON STOCK
1.8700
07-May-25 15:45:00
15 minutes delayed
Stocks
+0.0100
+0.54%
Today's range
1.8600 - 1.9600
ISIN
N/A
Source
NASDAQ
-
Nkarta Presents NKX019 Trial in Progress Poster at the 2021 ASH Annual Meeting and Exposition
13 Dec 2021 15:02:00 By Nasdaq GlobeNewswire
-
Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
12 Nov 2021 06:15:00 By Nasdaq GlobeNewswire
-
Nkarta Reports Third Quarter 2021 Financial Results and Business Update
10 Nov 2021 15:01:01 By Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conferences
04 Nov 2021 07:04:00 By Nasdaq GlobeNewswire
-
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
07 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
Nkarta to Present Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
01 Oct 2021 07:08:00 By Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conference
14 Sep 2021 07:32:00 By Nasdaq GlobeNewswire
-
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
12 Aug 2021 15:02:00 By Nasdaq GlobeNewswire
-
Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters
14 Jul 2021 06:00:00 By Nasdaq GlobeNewswire
-
Nkarta to Present at Upcoming Investor Conference
16 Jun 2021 06:00:00 By Nasdaq GlobeNewswire
-
Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term
14 Jun 2021 06:01:00 By Nasdaq GlobeNewswire
-
Nkarta Announces June 2021 Investor Conference Schedule
25 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
Nkarta Reports First Quarter 2021 Financial Results and Business Progress
13 May 2021 15:02:00 By Nasdaq GlobeNewswire
-
28 Apr 2021 07:02:00 By Nasdaq GlobeNewswire
-
Nkarta Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Business Progress
25 Mar 2021 15:03:00 By Nasdaq GlobeNewswire
-
Nkarta Announces February and March 2021 Investor Conference Schedule
17 Feb 2021 15:03:00 By Nasdaq GlobeNewswire